Related Experiment Video

Updated: Sep 21, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 17, 2014

Incidence of congenital heart disease: I. Postnatal incidence

J I Hoffman1

  • 1Department of Pediatrics, University of California-San Francisco 94143, USA.

Pediatric Cardiology
|May 1, 1995
PubMed

Insights

Congenital heart disease (CHD) incidence remains stable in industrialized nations, with advanced diagnostics improving detection of even minor heart defects. Global CHD lesion distribution is similar, though some conditions are less common in developing countries.

Area of Science:

  • Cardiology
  • Pediatrics
  • Public Health

Background:

  • Congenital heart disease (CHD) incidence in Western countries shows wide variation.
  • Improved diagnostic tools like echocardiography have enhanced detection capabilities.
  • Historical data may be skewed by diagnostic limitations and surgical advancements.

Purpose of the Study:

  • To analyze trends in congenital heart disease incidence.
  • To compare CHD lesion distribution globally.
  • To assess the impact of diagnostic advancements on reported incidence rates.

Main Methods:

  • Review of historical and contemporary epidemiological data on CHD.
  • Analysis of diagnostic capabilities over time, including echocardiography with Doppler color flow.
  • Comparison of CHD prevalence and lesion types between industrialized and developing nations.

Main Results:

  • No significant increase in CHD incidence observed over the past 20-30 years, despite improved diagnostics.
  • Echocardiography enables detection of previously undiagnosed asymptomatic or minor CHD.
  • CHD lesion distribution is broadly similar worldwide, with noted exceptions like aortic stenosis and coarctation of the aorta in developing countries.

Conclusions:

  • Current diagnostic advancements have refined CHD detection without altering underlying incidence.
  • Global surveillance of CHD is crucial, though data from underdeveloped countries remain limited.
  • Understanding lesion distribution aids in targeted healthcare resource allocation for congenital heart disease.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...